|Application:||Gene expression microarray analysis|
|Number of samples:||13|
|Release date:||Jul 27 2017|
|Last update date:||Jan 24 2018|
|Diseases:||Melanoma, Neoplasms, Colorectal Neoplasms|
|Dataset link||A ‘Synthetic-Sickness’ Screen for Senescence Re-engagement Targets in Mutant Cancer Backgrounds|
HCT116 colorectal cancer cells with heterozygous KRAS mutation and KRAS+/- cells in which the mutation is knocked out were reverse transfected with 50nM siRNA against ECT2 or scrambled control. 5 days post transfection, cells were harvested for RNA extraction.
W. Nicol Keith